Intrinsically disordered proteins are potential drug targets

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• Intrinsically disordered (ID) proteins lack stable structures and are common in eukaryotes.
• These proteins are frequently involved in disease pathways, making them attractive therapeutic targets.
• The feasibility of targeting structurally undefined proteins was previously uncertain.

Purpose of the Study:

• To investigate the potential of targeting intrinsically disordered proteins for therapeutic intervention.
• To explore the development of small molecules that can inhibit the functions of ID proteins.

Main Methods:

• Identification of small molecules that bind to disordered regions of specific ID proteins (e.g., c-Myc, Abeta).
• Optimization of initial small molecule hits to enhance binding affinity and specificity.

Main Results:

• Demonstrated that small molecules can effectively bind to and modulate the activity of ID proteins.
• Showcased successful optimization of lead compounds for improved therapeutic potential.

Conclusions:

• Targeting intrinsically disordered proteins is a viable strategy in drug discovery.
• Inhibiting ID protein interactions offers significant potential for developing novel therapeutics in chemical biology.